Chengwei Liu

Practice Areas

Alex Liu focuses on mergers and acquisitions, private equity investment & financing, and capital markets, with established expertise on takeover and restructuring of public companies, state-owned assets related transactions, cross-border M&A and red-chip restructuring.

Publications

Alex's published books include:

Solutions for Takeover of Listed Companies, Law Press 2023;

Chinese Capital Market Takeover and Restructuring Guide, Wolters Kluwer 2010;

Chinese Company and Securities Law: Investment Vehicles, Mergers and Acquisitions and Corporate Finance in China, Wolters Kluwer 2008 First Edition, 2016 Second Edition; and

Remedies in International Sales: Perspectives from CISG, UNIDROIT Principles and PECL, JurisNet 2007.

Work Highlights

In the field of merger and acquisitions, Alex has been involved in many representative deals, which include:

Takeover of control, such as,

Infore Group’s over RMB 8.88 billion takeover of KUCA (603816.SH);

Broadex’s (300548.SZ) takeover by YOFC (601869.SH; 06869.HK);

Orient Zirconic’s (002167.SZ) takeover by LB Group (002601.SZ);

Meiya Pico’s (300188.SZ) takeover by SDIC;

Sichuan Shuangma’s (000935.SZ) takeover by IDG Capital; and

Cangzhou Dahua’s (600230.SH) sale by a central SOE.

Restructuring by public companies, such as,

Zoomlion’s (000157.SZ; 01157.HK) carve-out by way of RoadRover’s (002813.SZ) backdoor listing;

Synermore Biologics’ sale to NUCIEN (688189.SH);

NuClover’s sale to Jieqiang Equipment (300875.SZ);

affiliates’ restructuring by SOE YNHC (001896.SZ); and

merger of Huabei Expressway (000916) by China Merchants Highway.

Cross-border M&A transactions, such as,

over RMB 3.3 billion strategic investment into CGN’s Brazilian subsidiary;

over RMB 18.47 billion takeover of Israel’s ADAMA by Sanonda (000553.SZ);

merger integration of Xiamen Port involving three A-shares and two HK listed companies;

combination of CR Pharmaceutical and Beijing Pharmaceutical involving four A-shares companies;

acquisition of Tianjin Port (600717.SH) by Tianjin Port Development (00382.HK) through shares exchange;

RTO of HanKore Environment (U9E.SGX) by Everbright International (00257.HK);

VSA injecting properties by CR Land (01109.HK);

sale of TNUVA to Bright Food by APAX Fund; and

acquisition of skiing resorts in Yabuli by Melco.

Red-chip or VIE restructuring, Alex’s representative clients include Xiyun, Douyu, EASOU Technology, Bangcle, Chunyu Yisheng, Baixing.com, and Baofeng Group etc.

In the field of PE investment and financing, Alex has represented numerous RMB or USD funds such as China Merchants Capital, CDB Capital, CIIF, Hony Capital, Goldstone, and Jinrong Street Capital etc., in investments ranging from technology, healthcare to energy sectors.

In capital markets, Alex has advised on the listings or additional issues on the stock exchanges in Shanghai, Shenzhen, Beijing, Hong Kong or US, including the IPO of China Resources Microelectronics (688396.SH) on SSE STAR, the first case in Chinese capital markets of an offshore red-chip company; Douyu.com (DOYU) and VisionChina (VISN)’s Nasdaq listing; Tong Ji Tang’s NYSE listing; Dynasty (00828), Huaying Highway (01823), Hongba Digital (00802) and Sanlin Global (019020)’s HKSE listing; Vanke’s B to H share conversion; and the delisting of Zhengzhou Gas, etc.

Experience

2011 – present Global Law Office

2010 – 2011 Jones Day (Beijing)

2004 – 2009 Global Law Office

Education

Languages Spoken

Chinese，English